Bioresource Technology 2012-07-01

Efficient conversion of 1,2-butanediol to (R)-2-hydroxybutyric acid using whole cells of Gluconobacter oxydans.

Chao Gao, Wen Zhang, Yuanli Huang, Cuiqing Ma, Ping Xu, Chao Gao, Wen Zhang, Yuanli Huang, Cuiqing Ma, Ping Xu

Index: Bioresour. Technol. 115 , 75-8, (2012)

Full Text: HTML

Abstract

(R)-2-Hydroxybutyric acid ((R)-2-HBA) is an important building block for azinothricin family of antitumour antibiotics and biodegradable poly(2-hydroxybutyric acid). However, optically active (R)-2-HBA could not be produced through microbial fermentation or chemical synthesis. Several biocatalytic methods have been reported for the production of (R)-2-HBA. Those processes used expensive and scarce substrates and would not be suitable for practical application. In this work, Gluconobacter oxydans DSM 2003 was confirmed to have the ability to produce (R)-2-HBA from 1,2-butanediol, a non-toxic and inexpensive compound that had a great potential for biotechnological processes. Under the optimal conditions, the biocatalytic process produced (R)-2-HBA at a high concentration (18.5 g l(-1)) and a high enantiomeric excess (99.7%). The biocatalysis process introduced in this study may provide a technically and economically interesting route for production of (R)-2-HBA.Copyright © 2011 Elsevier Ltd. All rights reserved.


Related Compounds

Related Articles:

(1)H NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urine.

2010-12-03

[J. Proteome Res. 9(12) , 6405-16, (2010)]

Kinetic resolution of 2-hydroxybutanoate racemic mixtures by NAD-independent L-lactate dehydrogenase.

2011-04-01

[Bioresour. Technol. 102(7) , 4595-9, (2011)]

Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a (GSD1a) by high-resolution (1)H NMR spectroscopy.

2007-06-01

[NMR Biomed. 20(4) , 401-12, (2007)]

Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer.

2012-07-01

[Clin. Cancer Res. 18(13) , 3677-85, (2012)]

Clinical applications of urinary organic acids. Part I: Detoxification markers.

2008-09-01

[Altern. Med. Rev. 13(3) , 205-15, (2008)]

More Articles...